메뉴 건너뛰기




Volumn 91, Issue 3, 2016, Pages E10-E11

Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation

Author keywords

[No Author keywords available]

Indexed keywords

IMATINIB; INTERLEUKIN 2 RECEPTOR ALPHA; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; PROTEIN; PROTEIN FIP1L1; PROTEIN TYROSINE KINASE; TRYPTASE; UNCLASSIFIED DRUG; CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR; FIP1L1-PDGFRA FUSION PROTEIN, HUMAN; ONCOPROTEIN;

EID: 84959172602     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.24273     Document Type: Letter
Times cited : (18)

References (6)
  • 1
    • 84944625994 scopus 로고    scopus 로고
    • World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management
    • Gotlib J. World Health Organization-defined eosinophilic disorders: 2015 update on diagnosis, risk stratification, and management. Am J Hematol 2015;90:1077-1089.
    • (2015) Am J Hematol , vol.90 , pp. 1077-1089
    • Gotlib, J.1
  • 2
    • 84862550125 scopus 로고    scopus 로고
    • Treatment-refractory idiopathic hypereosinophilic syndrome: Pitfalls and progress with use of novel drugs
    • Bleeker JS, Syed FF, Cooper LT, et al. Treatment-refractory idiopathic hypereosinophilic syndrome: Pitfalls and progress with use of novel drugs. Am J Hematol 2012;87:703-706.
    • (2012) Am J Hematol , vol.87 , pp. 703-706
    • Bleeker, J.S.1    Syed, F.F.2    Cooper, L.T.3
  • 3
    • 84883741186 scopus 로고    scopus 로고
    • Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia
    • Kosmider O, Itzykson R, Chesnais V, et al. Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia. Leukemia 2013;27:1946-1949.
    • (2013) Leukemia , vol.27 , pp. 1946-1949
    • Kosmider, O.1    Itzykson, R.2    Chesnais, V.3
  • 4
    • 79959794787 scopus 로고    scopus 로고
    • Clinical effect of point mutations in myelodysplastic syndromes
    • Bejar R, Stevenson K, Abdel-Wahab O, et al. Clinical effect of point mutations in myelodysplastic syndromes. N Engl J Med 2011;364:2496-2506.
    • (2011) N Engl J Med , vol.364 , pp. 2496-2506
    • Bejar, R.1    Stevenson, K.2    Abdel-Wahab, O.3
  • 5
    • 84931829725 scopus 로고    scopus 로고
    • ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia
    • Elliott MA, Pardanani A, Hanson CA, et al. ASXL1 mutations are frequent and prognostically detrimental in CSF3R-mutated chronic neutrophilic leukemia. Am J Hematol 2015;90:653-656.
    • (2015) Am J Hematol , vol.90 , pp. 653-656
    • Elliott, M.A.1    Pardanani, A.2    Hanson, C.A.3
  • 6
    • 84923021751 scopus 로고    scopus 로고
    • Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management
    • Pardanani A. Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management. Am J Hematol 2015;90:250-262.
    • (2015) Am J Hematol , vol.90 , pp. 250-262
    • Pardanani, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.